ÀÖ²¥´«Ã½

Floyd R. Livingston, MD

Division Chief

ÀÖ²¥´«Ã½ Children's Hospital, Florida 6535 ÀÖ²¥´«Ã½ Parkway Orlando, FL 32827

Biography

Dr. Livingston is the Division Chief of the Pediatric Pulmonary & Sleep Medicine for ÀÖ²¥´«Ã½ Children's Hospital. He has held this position for the last 28 years. Dr. Livingston holds the Professor of Pediatrics appointment at University of Central Florida College of Medicine and Associate Professor of Pediatrics appointment at Florida State University School of Medicine. He is Board-certified in both Pediatric Pulmonary and Pediatric Sleep Medicine and he has authored multiple scientific publications in journals such as, American Review of Respiratory Disease, Archives Biochemistry & Biophysics, Pediatric Pulmonology, American Journal of Respiratory Cell and Molecular Biology, Journal of Applied Physiology, Free Radical Biology & Medicine, Chest, Pediatrics, and the New England Journal of Medicine. He has been the Past-President of the American Lung Association of Central Florida and Medical Director of Boggy Creek Gang/ALA Asthma Camp and the AAP Asthma Medical Home Champion for the State of Florida. In 1999, Dr. Livingston received the Florida Voluntary Health Association (FVHA) Medical Volunteer of the Year Award. Dr. Livingston has been named both Orlando's Best Doctor and Top Doctor. Dr. Livingston is a member of the American Thoracic Society, American College of Chest Physicians, American Academy of Pediatrics, and American Academy of Sleep Medicine. He has won several teaching awards and research honors. His special research interests have been in Cystic Fibrosis, Childhood Asthma, Cellular Lung Defense and Pediatric Sleep Medicine.

Fellowship

  • Pulmonary Medicine - Children's Hospital of Los Angeles, 1992

Residency

  • Pediatrics - University of California Irvine Medical Center, 1988

Education

  • M.D. - Meharry Medical College, 1985

Board Certifications

  • American Board of Pediatrics/Pulmonology
  • American Board of Pediatrics/Sleep Medicine

  • What Are the Different Kinds of Apnea?; Curbside Consultation in Pediatric Sleep Disorders 49 Clinical Questions; (2024).

  • What Are the Different Stages of Sleep?; Curbside Consultation in Pediatric Sleep Disorders 49 Clinical Questions; (2024).

  • What is a Circadian Rhythm?; Curbside Consultation in Pediatric Sleep Disorders 49 Clinical Questions; (2024).

  • Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials; Lancet Respiratory Medicine; (2023).

  • Clinical Findings in Adolescents Hospitalized With EVALI; Novel Report on Coagulopathy; Hospital Pediatrics; (2022).

  • Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial; Thorax; (2022).

  • Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial; Lancet; (2019).

  • Fish oil supplementation in overweight/obese patients with uncontrolled asthma a randomized trial; Annals of the American Thoracic Society; (2019).

  • Effects of an antioxidant-enriched multivitamin in cystic fibrosis; American Journal of Respiratory and Critical Care Medicine; (2018).

  • Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial; Lancet Respiratory Medicine; (2017).

  • Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis; Pediatric Pulmonology; (2017).

  • Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function; Journal of Pediatrics; (2016).

  • Hypercapnic arousal responses in Prader-Willi syndrome; Chest; (1995).

  • Modulation of the alveolar macrophage respiratory burst by hydroperoxides; Free Radical Biology and Medicine; (1995).

  • Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome; Journal of Applied Physiology; (1994).

  • Stimulation of the rat alveolar macrophage respiratory burst by extracellular adenine nucleotides; Am J Respir Cell Mol Biol; (1993).

  • Sublethal oxidant stress induces a reversible increase in intracellular calcium dependent on NAD(P)H oxidation in rat alveolar macrophages; Archives of Biochemistry and Biophysics; (1992).

  • Hypercapnic and hypoxic ventilatory responses in parents and siblings of children with congenital central hypoventilation syndrome; American Review of Respiratory Disease; (1991).

  • STIRLING MODULE DEVELOPMENT OVERVIEW.; JPL Publication; (1984).

  • SATELLITE POWER SYSTEM (SPS) ENVIRONMENTAL IMPACTS ASSESSMENT.; Los Angeles Counc Eng Sci Proc Ser; (1978).

  • Relaxation distance and equilibrium electron density measurements in hydrogen-helium plasmas; AIAA Journal; (1976).

  • TOWARD UNDERSTANDING THE CONICAL ARC-CHAMBER DRIVER.; undefined; (1973).

  • Planetary entry body heating rate measurements in air and Venus atmospheric gas up to T = 15,000°K; AIAA Journal; (1971).